Erratum: US panel advises resumption of gene trials

    On p. 1068 of the November 2002 issue (Nat. Biotechnol. 20, 1068; 2002), the Business and Regulatory News Analysis story “US panel advises resumption of gene trials,” contains an error. The “US Recombinant DNA Advisory Council” should be the “FDA Biological Response Modifiers Advisory Committee”. Nature Biotechnology regrets the error.

    Additional information

    The online version of the original article can be found at 10.1038/nbt1102-1068

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Erratum: US panel advises resumption of gene trials. Nat Biotechnol 21, 132 (2003). https://doi.org/10.1038/nbt0203-132c

    Download citation